Article
Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge.
Journal of virology - 1 Sept 2015
Bukh Jens, Engle Ronald E, Faulk Kristina, Wang Richard Y, Farci Patrizia, Alter Harvey J, Purcell Robert H
Abstract excerpt
The importance of neutralizing antibodies (NAbs) in protection against hepatitis C virus (HCV) remains controversial. We infused a chimpanzee with H06 immunoglobulin from a genotype 1a HCV-infected patient and challenged with genotype strains efficiently neutralized by H06 in vitro. Genotype 1a NAbs afforded no protection against genotype 4a or 5a. Protection against homologous 1a lasted 18 weeks, but infection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
